# Raiz Diagnostics

Source: https://onco.cc/companies/raiz-diagnostics/  
OnCo record `raiz-diagnostics` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Raiz Diagnostics is a Boston company building a test that reads which genes are switched on in a lymphoma sample, to give a diagnosis that guides treatment at lower cost.

## Summary

Raiz Diagnostics, Inc., of Boston, describes its product as an end-to-end, treatment-defining lymphoma diagnosis and offers limited beta access. In fiscal year 2026 the National Cancer Institute funded its SBIR project on a cost-effective gene expression assay for lymphoma diagnosis intended for broad implementation (5R44CA310364-02, USD 520,000).

## Fields

- Kind: Company
- Last checked: 2026-11-04
- Also known as: RAIZ DIAGNOSTICS, INC.
- HQ: Boston, MA
- Type: diagnostics
- Website: https://www.raizdx.com/

## Notes

- The company website was a holding page with a short description when read on 4 November 2026; the assay is described from the NIH RePORTER record.

## Sources

- Official website: https://www.raizdx.com/
- NIH RePORTER: 5R44CA310364-02: https://reporter.nih.gov/project-details/11417251

## Connected records

- cancers: [Non-Hodgkin lymphoma (all types)](https://onco.cc/cancers/non-hodgkin-lymphoma/)
- fronts: [Diagnostics & Biomarkers](https://onco.cc/fronts/diagnostics/)
- technologies: [Gene-expression prognostic assays](https://onco.cc/technologies/gene-expression-prognostic-assays/)

---
JSON: https://onco.cc/api/v1/entities/raiz-diagnostics.json